CASTLE BIOSCIENCES, INC. (CSTL) Operating margin 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.4%FY2025 · since FY2018: -16.8% → -12.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.4% | -15.0 pp |
| FY2024 | 2.6% | +33.5 pp |
| FY2023 | -30.9% | +22.2 pp |
| FY2022 | -53.2% | -10.6 pp |
| FY2021 | -42.6% | -32.2 pp |
| FY2020 | -10.4% | -24.6 pp |
| FY2019 | 14.1% | +31.0 pp |
| FY2018 | -16.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →